PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.50%
Negative net income growth while CRWD stands at 30.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-11.29%
Negative yoy D&A while CRWD is 6.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-130.74%
Both reduce yoy usage, with CRWD at -200.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-130.74%
Negative yoy usage while CRWD is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
79.65%
Well above CRWD's 14.15%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-23.78%
Both yoy CFO lines are negative, with CRWD at -13.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
52.40%
CapEx growth well above CRWD's 64.44%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
76.62%
Purchases well above CRWD's 31.64%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with CRWD at -9.26%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
12.06%
Lower net investing outflow yoy vs. CRWD's 52.10%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
192.22%
We slightly raise equity while CRWD is negative at -200.00%. John Neff sees competitor possibly preserving share count or buying back shares.
27.34%
Buyback growth of 27.34% while CRWD is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.